After 80 years of prohibition, Cannabis Sativa is being accepted on a worldwide scale for medicinal and general consumption. As consequence, investigations into CBD’s effects have begun. There is much to learn about CBD. Particularly, studies are necessary on best presentation and dosage per indication. At this point, we know CBD is not causing serious adverse effect. Thus, from a safety standpoint, it is acceptable for general consumption. In vitro and in vivo animal studies identify a broad spectrum of activity including anti-epileptic, anti-inflammatory, analgesic, anxiolytic, neuroprotective, anti-tumor and sleep inducing effects. Although CBD shows a wide spectrum of activity, its potency is uncertain. This is due to its poor bioavailability and variable metabolism. It is likely through general consumption and observational study that we will learn the most. What’s certain is that CBD is now exposed and will be exploited for multiple purposes and in multiple ways.
